anti-angiomotin antibodies (BioInvent)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nameanti-angiomotin antibodies (BioInvent)
Drug Alias NameB-06 (BioInvent)anti-angiomotin antibodies (Karolinska Institute)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionAngiomotin inhibitors
TargetsAngiomotin
Therapy Area/IndicationsRetinal DiseasesNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKarolinska Institutet
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsRetinal DiseasesNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A